{"nct_id":"NCT04969861","title":"BEMPEG With Pembrolizumab vs Pembrolizumab Alone in Patients With Metastatic or Recurrent HNSCC (PROPEL-36)","status":"TERMINATED","status_verified_date":"2022-11","start_date":"2022-03-09","start_date_type":"ACTUAL","primary_completion_date":"2022-04-22","primary_completion_date_type":"ACTUAL","completion_date":"2022-04-22","completion_date_type":"ACTUAL","phases":["PHASE2","PHASE3"],"tickers":["NKTR"]}